PADOAN, ANDREA
 Distribuzione geografica
Salva come PNG Salva come JPEG
Continente #
NA - Nord America 11.065
EU - Europa 2.286
AS - Asia 2.056
SA - Sud America 44
Continente sconosciuto - Info sul continente non disponibili 16
AF - Africa 9
OC - Oceania 8
Totale 15.484
Salva come PNG Salva come JPEG
Nazione #
US - Stati Uniti d'America 11.035
CN - Cina 992
IT - Italia 921
SG - Singapore 793
FI - Finlandia 296
SE - Svezia 245
DE - Germania 206
FR - Francia 154
RU - Federazione Russa 128
GB - Regno Unito 112
VN - Vietnam 80
HK - Hong Kong 70
UA - Ucraina 65
NL - Olanda 52
IN - India 35
BR - Brasile 32
CA - Canada 29
IE - Irlanda 29
JP - Giappone 22
AT - Austria 18
EU - Europa 16
GR - Grecia 13
IL - Israele 12
RO - Romania 12
ES - Italia 11
TR - Turchia 10
AU - Australia 7
ID - Indonesia 6
IQ - Iraq 6
SI - Slovenia 6
CL - Cile 5
IR - Iran 4
KR - Corea 4
AR - Argentina 3
BE - Belgio 3
PH - Filippine 3
PK - Pakistan 3
PL - Polonia 3
TH - Thailandia 3
YE - Yemen 3
AZ - Azerbaigian 2
CZ - Repubblica Ceca 2
GE - Georgia 2
HR - Croazia 2
LT - Lituania 2
LV - Lettonia 2
MA - Marocco 2
ME - Montenegro 2
MW - Malawi 2
OM - Oman 2
VE - Venezuela 2
ZA - Sudafrica 2
ZW - Zimbabwe 2
AE - Emirati Arabi Uniti 1
CH - Svizzera 1
DZ - Algeria 1
EC - Ecuador 1
LK - Sri Lanka 1
LU - Lussemburgo 1
MX - Messico 1
NZ - Nuova Zelanda 1
PE - Perù 1
TW - Taiwan 1
UZ - Uzbekistan 1
Totale 15.484
Salva come PNG Salva come JPEG
Città #
Fairfield 1.495
Woodbridge 1.216
Chandler 971
Ann Arbor 923
Houston 912
Ashburn 735
Cambridge 573
Singapore 568
Wilmington 502
Seattle 481
Boardman 345
Santa Clara 310
Jacksonville 257
Princeton 223
Beijing 213
Des Moines 212
Medford 204
Padova 175
San Diego 173
Helsinki 146
Nanjing 115
Roxbury 85
Milan 82
Dong Ket 79
Hong Kong 69
Nanchang 51
Shenyang 48
Guangzhou 39
Jinan 38
Hebei 35
New York 29
Rome 29
London 28
Changsha 27
Dublin 27
Los Angeles 25
Shanghai 24
Zhengzhou 24
Tianjin 22
Jiaxing 21
Nuremberg 18
Washington 18
Dallas 17
Frankfurt am Main 17
Redwood City 17
Munich 16
Naples 15
Hefei 14
Taizhou 14
Turin 14
Kunming 13
Norwalk 12
Venezia 12
Florence 11
Lanzhou 11
Lappeenranta 11
Bologna 10
Casier 10
Ogden 10
Trento 10
Berlin 9
Mestre 9
Limena 8
Phoenix 8
Pune 8
Vienna 8
Amsterdam 7
Genoa 7
Kharkiv 7
Kilburn 7
Legnaro 7
Montreal 7
Ningbo 7
Stockholm 7
Taiyuan 7
Udine 7
Venice 7
Borås 6
Chicago 6
Detroit 6
Falls Church 6
Haikou 6
Hangzhou 6
Palermo 6
Paris 6
Shenzhen 6
Trieste 6
Chengdu 5
Cles 5
Council Bluffs 5
Fuzhou 5
Hounslow 5
Nave 5
Ramat Gan 5
Rockville 5
Sydney 5
Tokyo 5
Treviso 5
Verona 5
Ancaster 4
Totale 12.052
Salva come PNG Salva come JPEG
Nome #
“Modello di indicatori di qualità” dell’IFCC WG-LEPS: Risultati ed evoluzione del progetto. 383
Clarithromycin Resistance, Tumor Necrosis Factor Alpha Gene Polymorphism and Mucosal Inflammation Affect H. pylori Eradication Success. 180
Blood expression of matrix metalloproteinases 8 and 9 and of their inducers S100A8 and S100A9 supports diagnosis and prognosis of PDAC-associated diabetes mellitus 167
A Randomized Trial of Pharmacogenetic Warfarin Dosing in Naive Patients with Non-Valvular Atrial Fibrillation 163
An approach for estimating measurement uncertainty in medical laboratories using data from long-term quality control and external quality assessment schemes 150
Improving IBD diagnosis and monitoring by understanding preanalytical, analytical and biological fecal calprotectin variability 149
TNFA Haplotype Genetic Testing Improves HLA in Estimating the Risk of Celiac Disease in Children. 147
Mass spectrometry measurement of plasma hepcidin for the prediction of iron overload. 146
Quality indicators to detect pre-analytical errors in laboratory testing 141
Computer-based-limited and personalised education management maximise appropriateness of vitamin D, vitamin B12 and folate retesting 141
Pancreatic cancer biomarkers discovery by surface-enhanced laser desorption and ionization time-of-flight mass spectrometry 140
CA125 reference values change in male and postmenopausal female subjects 134
New screening tests enrich anti-transglutaminase results and support a highly sensitive two-test based strategy for celiac disease diagnosis. 131
PDAC-derived exosomes enrich the microenvironment in MDSCs in a SMAD4-dependent manner through a new calcium related axis 130
Performance criteria and quality indicators for the post-analytical phase 127
A new sampling device for faecal immunochemical testing: haemoglobin stability is still an open issue 124
Inflammation and pancreatic cancer: molecular and functional interactions between S100A8, S100A9, NT-S100A8 and TGFβ1 123
Peptidomic and proteomic analysis of stool for diagnosing IBD and deciphering disease pathogenesis 123
Flow cytometry CD4+CD26−CD38+ lymphocyte subset in the microenvironment of Hodgkin lymphoma-affected lymph nodes 122
Analytical validation of a Biochip prototype for integrated analysis of AFP-IgM and SCCA-IgM serum biomarkers in patients with liver cirrhosis and hepatocellular carcinoma 118
SMAD4 loss enables EGF, TGFβ1 and S100A8/A9 induced activation of critical pathways to invasion in human pancreatic adenocarcinoma cells 118
Plasma and dried blood spot lysosphingolipids for the diagnosis of different sphingolipidoses: A comparative study 117
What information on measurement uncertainty should be communicated to clinicians, and how? 113
Altered Intracellular Calcium Fluxes in Pancreatic Cancer Induced Diabetes Mellitus: Relevance of the S100A8 N-Terminal Peptide (NT-S100A8) 111
Monitoring quality indicators in laboratory medicine does not automatically result in quality improvement. 111
Chemiluminescence and ELISA-based serum assays for diagnosing and monitoring celiac disease in children: a comparative study. 111
DNA repair pathways and mitochondrial DNA mutations in gastrointestinal carcinogenesis 109
Complete blood count at the ED: Preanalytic variables for hemoglobin and leukocytes 108
SARS-CoV-2 antibody dynamics and transmission from community-wide serological testing in the Italian municipality of Vo' 108
Serum YKL-40 following resection for cerebral glioblastoma 107
An integrated system for monitoring the quality of sample transportation. 107
Hyperglycemia-induced S100A8 and S100A9 expression target AKT, mTOR and NF-kB signalling in pancreatic cancer cells 104
Decision Support and Patient Safety 103
Heat-induced transcription of diphtheria toxin A or its variants, CRM176 and CRM197: implications for pancreatic cancer gene therapy. 103
Validation model of a laboratory-developed method for the ISO15189 accreditation: The example of salivary cortisol determination 100
Analytical and clinical performances of five immunoassays for the detection of SARS-CoV-2 antibodies in comparison with neutralization activity 98
Pancreatic cancer (PC) gene therapy with heat inducible diphtheria toxin variant CRM197 (DTA197): in vivo preliminary results. 97
Automated saliva processing for LC-MS/MS: Improving laboratory efficiency in cortisol and cortisone testing 97
Biological variability of lymphocyte subsets of human adults’ blood 93
C-peptide and insulin assays with the Mindray CL-2000i: Precision and comparability with different methods 92
AESKULISA and H-TTG/DGP screen for celiac disease diagnosis. 91
Genetics in TNF-TNFR pathway: A complex network causing spondyloarthritis and conditioning response to anti-TNFa therapy 91
Pancreatic cancer gene therapy with heat inducible diphtheria toxin variant CRM197 (DTA197): in vivo preliminary results. 90
Pharmacokinetic and pharmacodynamic re-evaluation of a genetic-guided warfarin trial 90
Measurement uncertainty in laboratory reports: A tool for improving the interpretation of test results 90
Mild SARS-CoV-2 Infections and Neutralizing Antibody Titers 90
MMP9 and S100A9 expression in peripheral blood mononuclear cells (PBMC) are correlated with PDAC and with PDAC-associated diabetes mellitus. 89
Pancreatic tumors and immature immunosuppressive myeloid cells in blood and spleen: role of inhibitory co-stimulatory molecules PDL1 and CTLA4. An in vivo and in vitro study. 87
PCA3 score of 20 could improve prostate cancer detection: Results obtained on 734 Italian individuals 86
Relevance of pre-analytical blood management on the emerging cardiovascular protein biomarkers TWEAK and HMGB1 and on miRNA serum and plasma profiling 86
Impact of HIV-1 Infection and Antiretroviral Therapy on Bone Homeostasis and Mineral Density in Vertically Infected Patients 85
Quality of plasma samples and BD Vacutainer Barricor tubes: Effects of centrifugation 84
Reproducibility in urine peptidome profiling using maldi-tof 82
Preanalytical challenges - time for solutions 82
Pancreatic cancer (PC) gene therapy with heat inducible diphtheria toxin variant CRM197 (DTA197): in vivo preliminary data. 81
MALDI-TOF/MS biomarkers discovery for pancreatic cancer diagnosis: emerging role of apolipoprotein A1 and complement C3 81
Analytical performances of a chemiluminescence immunoassay for SARS-CoV-2 IgM/IgG and antibody kinetics 81
Percentile transformation and recalibration functions allow harmonization of thyroid-stimulating hormone (TSH) immunoassay results 81
The pancreatic cancer (PC) derived S100A8 N-terminal peptide (NT-S100A8) augments intracellular Ca2+ ([Ca2+]i) ,oscillations and insulin release. 80
The Impact of Pre-Analytical Conditions on Human Serum Peptidome Profiling 80
A multicenter study for the evaluation of the reference interval for TSH in Italy (ELAS TSH Italian Study) 80
External quality assessment programs in the context of ISO 15189 accreditation 80
SMAD-4 RELATED AND UNRELATED SOLUBLE FACTORS AND EXOSOMES CO-OPERATE IN DETERMINING PDAC IMMUNOEVASION 80
S100B as a new fecal biomarker of inflammatory bowel diseases 79
Serum biomarkers of pancreatic cancer (PC) and pancreatic cancer derived diabetes mellitus (DM). 79
QUALITY INDICATORS IN LABORATORY MEDICINE: THE EXPERIENCE OF A LARGE LABORATORY 78
The inflammatory calcium binding protein S100A8 and its N-terminal proteolytic fragment interact with transforming growth factor-beta1 (TGF-B1) and alter AKT, mTOR and NF-kB cancer cell signalling 78
Effects of sample transportation on commonly requested laboratory tests. 78
Extra-analytical sources of uncertainty: which ones really matter? 77
KLK3 and steroid 5-alpha reductase type II (SRD5A2) gene polymorphisms might affect clinical reliability of serum PSA measurement. 76
Hypergycemia-induced S100A8 and S100A9 expression target AKT, MTor and N-KB signalling in pancreatic cancer cells. 76
MALDI-TOF peptidomic analysis of serum and post-prostatic massage urine specimens to identify prostate cancer biomarkers 76
NT-S100A8 effects on cell signalling. 75
MALDI-TOF/MS Biomarkers Discovery for Pancreatic Cancer Diagnosis: Emerging Role of Apolipoprotein A1 and Complement C3 75
IgA-Ab response to spike glycoprotein of SARS-CoV-2 in patients with COVID-19: A longitudinal study 75
A new laboratory friendly platform to detect the celiac disease associated HLA-DQ2 and DQ8 haplotype. 74
Maldi-TOF/MS biomarkers discovery for pancreatic cancer diagnosis: emerging role of apolipoprotein A1 and Complement C3. 74
Prothrombotic state in glioblastoma multiforme: an evaluation of the procoagulant activity of circulating microparticles. 74
Pancreatic cancer-derived soluble mediators induce dendritic cells to acquire an immunosuppressive phenotype by downregulating CTLA4. 74
MALDI-TOF/MS PROTEOMIC SIGNATURE OF PRE-ANALYTICAL SAMPLE QUALITY 73
Celiac disease diagnosis and monitoring: comparison between chemiluminescence and ELISA antitransglutaminase and anti-deamidated gliadin peptides measurements 73
Biomarkers: Biomarker Panels and Multiple Readouts 73
Polygenic and multifactorial scores for pancreatic ductal adenocarcinoma risk prediction 73
NT-S100A8 inhibits insulin release and activates AKT and NF_KB cell signalling in pancreatic cancer (PC) cells. 72
Inflammation and pancreatic cancer: Focus on metabolism, cytokines, and immunity 71
Early detection of CD4+CD26-CD38+ subset in hodgkin’s lymph nodes 70
Usefulness of MALDI-TOF/MS Identification of Low-MW Fragments in Sera for the Differential Diagnosis of Pancreatic Cancer. 70
Prothrombotic state in glioblastoma multiforme: an evaluation of the procoagulant activity of circulating microparticules. 69
Pancreatic cancer biomarkers discovery by SELDI-TOF-MS. 69
Verification of examination procedures in clinical laboratory for imprecision, trueness and diagnostic accuracy according to ISO 15189:2012: a pragmatic approach 69
Analogs of vitamin E epitomized by alpha-tocopheryl succinate for pancreatic cancer treatment: in vitro results induce caution for in vivo applications. 69
Pancreatic cancer biomarkers discovery by SELDI-TOF-MS. 68
Analogues of vitamin E epitomised by alpha-tochopherol succinate (alpha-TOS) for pancreatic cancer treatment: in vitro results induce caution for in vivo applications 68
NT-S100A8 inhibits insulin release and activates AKT and NF_KB cell signalling in pancreatic cancer (PC) cells. 68
Quality indicators in laboratory medicine: state-of-the-art, quality specifications and future strategies 67
Pancreatic cancer biomarkers discovery by SELDI-TOF-MS. 67
Celiac disease diagnosis and monitoring; comparison between chemiluminescence and ELISA anti-transglutaminase and anti-deamidated gliadin peptides measurements. 67
Clinical relevance of circulating and splenic immature myeloid cells in pancreatic diseases. 66
Clinical performances of an ELISA for SARS-CoV-2 antibody assay and correlation with neutralization activity 66
Pancreatic cancer biomarkers discovery by SELDI-TOF-MS 65
Totale 9.764
Salva come PNG Salva come JPEG
Categoria #
all - tutte 65.915
article - articoli 48.393
book - libri 0
conference - conferenze 0
curatela - curatele 0
other - altro 0
patent - brevetti 0
selected - selezionate 0
volume - volumi 349
Totale 114.657
Salva come PNG Salva come JPEG


Totale Lug Ago Sett Ott Nov Dic Gen Feb Mar Apr Mag Giu
2019/20201.137 0 0 0 0 0 0 0 254 254 335 160 134
2020/20211.978 78 153 109 170 75 90 85 145 212 265 222 374
2021/20222.384 121 341 196 123 59 217 157 183 113 79 200 595
2022/20232.195 446 211 40 236 360 303 23 142 253 28 106 47
2023/20241.530 50 154 152 136 105 130 205 123 66 107 137 165
2024/20252.325 70 357 292 263 777 154 327 85 0 0 0 0
Totale 15.743